2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review
FDA Approves First DNA Medicine to Reduce Repeat Airway Surgeries On October 30th, the FDA published a report that Voceryq ...




